118 results
Page 3 of 6
8-K
EX-10.2
is5h fqr49
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-2.1
buwla2 3my4du
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.1
8fyal5j
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
84ryujipk5wwdpq8s
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
fia16
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
9yhyn
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
ur7cxdt8v avcmr1vlv
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
aem9yd 9967
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
yck8vs2vn
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-10.1
e773vkwehvcct
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
a4m5hfy
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm